Document is current
Any future updates will be listed below
-
Authors
Zhao, Yi
Ling, Fayang
Qin, Yalu
Xie, Wen
Qi, Wenchuan
Nie, Qian
Zhang, Hongcai
Han, Mingjun
Zhao, Jue
Liu, Lei
Hu, Lin
Xiao, Juan
Li, Wufeng
Liang, Fanrong
Zheng, Qianhua
-
Funding
Funding for this research was provided by:
Natural Science Foundation of Sichuan Province (No. 2023NSFSC1819)
Scientific Talents Promotion Program of Xinglin Scholars (No. BSH2020023)
National Natural Science Foundation of China (No.82205286)
the Regional Cooperation Program of National Natural Science Foundation of China (No.U21A20404)
Projects in the Management of Traditional Chinese Medicine in Sichuan Province (No.2023MS193)
- License Information
-
More Information
Article History
Received: 3 April 2024
Accepted: 6 August 2024
First Online: 14 August 2024
Declarations
:
: The trial will be conducted in accordance with the requirements of the Declaration of Helsinki. The whole project has been approved by the Ethics Committee of the Affiliated Hospital of Chengdu University of Traditional Chinese Medicine (No. 2023KL-065) and registered in the China Clinical Trial Registry () with registration number ChiCTR2400081117, registered on February 22, 2024. Before randomization, patients are required to sign an informed consent form. Subject’s personal information is confidential, participation in the study is entirely voluntary, with the right to withdraw at any time during any study phase.
: Not applicable.
: The authors declare no competing interests.
: The trial began on April 1, 2023, and is expected to end on March 31, 2025.
